IRCT20220411054497N1 IRCT 2022-10-03 Qazvin University of Medical Sciences Evaluation of the effectiveness of letrozole in EP treatment Comparison evaluation of letrozol metoretoxate treatment in patients with ectopic pregnancy 2022-10-23 anticipated 48 Complete https://irct.ir/trial/62895 interventional Randomization: Not randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment. 2-3 Ectopic Pregnancy. Intervention 1: The intervention group: includes a group of 24 people receiving letrozole for the treatment of EP, after explaining the benefits and side effects of both treatment methods and obtaining informed consent from them, 2.5 mg tablets every twelve hours for ten days receive letrozole. Intervention 2: The intervention group: includes a group of 24 people receiving methotrexate for the treatment of EP, who after explaining the benefits and complications of both treatment methods and obtaining informed consent from them, methotrexate ampoules with a dose of fifty mg per square meter It is done for them in a muscular way. Yes - There is a plan to make this available What will be shared: Only information from the study participants will be published that is relevant to the outcome of the study and that they have been informed of their consent prior to the start of the study. When: The access period started at the beginning of 1401 and continues until the examination of 24 patients receiving letrozole treatment To whom: This information is available in the early stages for researchers and university-level research supervisors Conditions: This information is available in the early stages for researchers and university-level research supervisors Where to obtain: To receive comments, you can refer to the main project manager and then the executive project manager How to obtain: Submitting a request to the research director After reviewing by the project manager, a request to the research vice chancellor of the university Comments: